Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature
Conclusion: Our case report presents a novel pattern of RRP induced by anti-PD-1 blockade Camrelizumab 2 years after radiotherapy. This indicates that previous radiotherapy combined with subsequent anti-PD-1 blockade has a potential to cause overlapping damage to lung, suggesting that intensive attention might be needed for patients who are treated with anti-PD-1 blockade in conjunction with a prior history of thoracic radiation.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Alimta | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Cough | Immunotherapy | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Prednisolone